Cancer Vaccine Design Gets Personal

Many new personalized cancer vaccines (PVCs) platforms are at or near the clinical stage and showing great promise. Design concepts include viral, bacterial, and synthetic vectors as well as the direct use of tumor cells to sensitize the immune system. Each system comes with its own set of trade-offs in terms of manufacturing process, safety, and ease of use for patients.

The post Cancer Vaccine Design Gets Personal appeared first on GEN - Genetic Engineering and Biotechnology News.